SpectraCure AB (publ) OMXSTO:SPEC:
SIGNS AGREEMENT WITH CHEPLAPHARM FOR VERTEPORFIN SUPPLY
Spectracure Signs Agreement With Cheplapharm For Verteporfin Supply
Earlier from Spectracure Ab
- Spectracure Q-Pro Patent Approved In Japan
- Spectracure Gets Approval To Commence Clinical Trial
- Spectracure Appoints Johannes Swartling As CEO
- Spectracure Reports Positive Results In Prostate Cancer Study